When are you inclined to use combination therapy with a DMARD and biologic, and when is monotherapy with a DMARD alone a reasonable strategy?

When are you inclined to use combination therapy with a DMARD and biologic, and when is monotherapy with a DMARD alone a reasonable strategy?

When are you inclined to use combination therapy with a DMARD and biologic, and when is monotherapy with a DMARD alone a reasonable strategy?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Michael Ehrenstein, MD

Michael Ehrenstein, MD

Professor of Rheumatology
University College Hospital
University College of London School of Medicine
London, UK